Legal & General Group PLC Zai Lab LTD Transaction History

Legal & General Group PLC

$440 Billion
Q2 2024

A detailed history of Legal & General Group PLC transactions in Zai Lab LTD stock. As of the latest transaction made, Legal & General Group PLC holds 209,596 shares of ZLAB stock, worth $6.59 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

209,596

Previous 793,314 73.58%

Holding current value

$6.59 Million

Previous $12.7 Million 71.42%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$13.72 - $21.55 $8.01 Million - $12.6 Million	-583,718 Reduced 73.58%	209,596 $3.63 Million
Q1 2024 May 14, 2024	SELL	$15.95 - $26.8 $656,230 - $1.1 Million	-41,143 Reduced 4.93%	793,314 $12.7 Million
Q4 2023 Feb 15, 2024	BUY	$22.97 - $30.58 $3.21 Million - $4.28 Million	139,832 Added 20.13%	834,457 $22.8 Million
Q3 2023 Nov 14, 2023	SELL	$22.72 - $31.49 $5.45 Million - $7.56 Million	-239,977 Reduced 25.68%	694,625 $16.9 Million
Q2 2023 Aug 14, 2023	BUY	$25.3 - $39.67 $4.1 Million - $6.43 Million	161,982 Added 20.97%	934,602 $25.9 Million
Q1 2023 May 15, 2023	BUY	$30.21 - $48.1 $1.37 Million - $2.18 Million	45,275 Added 6.22%	772,620 $25.7 Million
Q4 2022 Feb 14, 2023	BUY	$22.28 - $38.71 $310,984 - $540,314	13,958 Added 1.96%	727,345 $22.3 Million
Q3 2022 Nov 14, 2022	BUY	$34.2 - $51.69 $3.09 Million - $4.67 Million	90,328 Added 14.5%	713,387 $24.4 Million
Q2 2022 Aug 22, 2022	BUY	$23.14 - $49.68 $1.28 Million - $2.74 Million	55,140 Added 9.71%	623,059 $21.6 Million
Q1 2022 May 16, 2022	BUY	$27.77 - $64.4 $52,318 - $121,329	1,884 Added 0.33%	567,919 $25 Million
Q4 2021 Feb 14, 2022	BUY	$54.9 - $105.21 $6.35 Million - $12.2 Million	115,609 Added 25.67%	566,035 $35.6 Million
Q3 2021 Nov 15, 2021	BUY	$105.0 - $178.37 $284,865 - $483,917	2,713 Added 0.61%	450,426 $47.5 Million
Q2 2021 Aug 12, 2021	BUY	$125.11 - $180.0 $166,521 - $239,580	1,331 Added 0.3%	447,713 $79.2 Million
Q1 2021 May 17, 2021	SELL	$126.27 - $191.71 $911,921 - $1.38 Million	-7,222 Reduced 1.59%	446,382 $59.6 Million
Q4 2020 Feb 12, 2021	BUY	$81.94 - $135.34 $1.49 Million - $2.47 Million	18,230 Added 4.19%	453,604 $61.4 Million
Q3 2020 Nov 13, 2020	BUY	$73.3 - $89.48 $16.5 Million - $20.1 Million	224,642 Added 106.6%	435,374 $36.2 Million
Q2 2020 Aug 14, 2020	BUY	$48.82 - $82.53 $2.76 Million - $4.67 Million	56,603 Added 36.72%	210,732 $17.3 Million
Q1 2020 May 14, 2020	BUY	$39.1 - $62.9 $5.7 Million - $9.17 Million	145,765 Added 1742.77%	154,129 $7.94 Million
Q4 2019 Feb 13, 2020	BUY	$29.79 - $43.06 $185,651 - $268,349	6,232 Added 292.31%	8,364 $348,000
Q3 2018 Nov 20, 2018	BUY	$17.8 - $25.35 $37,949 - $54,046	2,132 New	2,132 $42,000

Others Institutions Holding ZLAB

# of Institutions

116

Shares Held

40.8M

Call Options Held

63.1K

Put Options Held

420K

View Full List

About Zai Lab Ltd

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $3.08B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

More about ZLAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Account

Legal & General Group PLC Zai Lab LTD Transaction History